Toripalimab
Medication
Toripalimab ▸ Facts ▸ Comments ▸ News ▸ Videos
Toripalimab, sold under the brand name Loqtorzi, is a monoclonal antibody used for the treatment of melanoma and nasopharyngeal carcinoma. Toripalimab is a recombinant humanized programmed cell death protein 1 (PD-1) monoclonal antibody that acts as a checkpoint inhibitor.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Dr Reddy launches world's 1st immuno-onco drug for nasopharyngeal cancer in IndiaDr Reddyβs Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India. Toripalimab, a PD-1 inhibitor, provides a new treatment option for this rare head..IndiaTimes - Published |
| Search this site and the web: |
